Psoriatic arthritis change, recommencement or demonstration of response authority application form (PB260)

Use this form to apply for changing, recommencing or demonstration of response for PBS subsidised treatment with a biological agent for adult patients with psoriatic arthritis.

Biological agent refers to:

  • adalimumab
  • certolizumab pegol
  • etanercept
  • golimumab
  • guselkumab
  • infliximab
  • ixekizumab
  • secukinumab
  • tofacitinib
  • upadacitinib
  • ustekinumab.

Download and complete the Psoriatic arthritis - change or recommencement or demonstration of response authority application form.

This PDF is fillable. You can fill it out on your device, or print it and complete it by hand.

You can upload this form in HPOS.

If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.

Page last updated: 1 October 2021